2025: A Bright Year Ahead for Future Pharmacology
Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK
†
Editor-in-Chief of Future Pharmacology.
Future Pharmacol. 2025, 5(1), 2; https://doi.org/10.3390/futurepharmacol5010002
Submission received: 23 December 2024
/
Accepted: 23 December 2024
/
Published: 1 January 2025
As 2024 is coming to an end, let us reflect on Future Pharmacology’s achievements to better understand what is promising to be a bright year ahead. The Future Pharmacology team remains steadfast in its mission to promote open science, enabling scientists to collaborate more effectively and rapidly in order to provide innovative clinical solutions for complex medical issues. This will be carried out with current and future research being published, with all these academic outputs being both validated and of high quality.
An overview of the 2024 data for Future Pharmacology may help to better assess our overall improvement in quality and scientific outputs. So far, we have published 49 papers. Dr. Giuseppe Floresta from the University of Catania, Italy, has recently been added as a new editorial board member. An Early Career Editorial Board (ECEB) Project has been announced (https://www.mdpi.com/journal/futurepharmacol/announcements/9245), and the first Early Career Editorial Board of Future Pharmacology will be established soon.
We had the opportunity to promote Future Pharmacology at various events in 2024 (Table 1).
I am pleased to inform you that, over the last 12 months, the three papers have attracted the most views (Table 2).
Finally, I will share some excellent news related to Indexing! Our journal was indexed in the Emerging Sources Citation Index (ESCI)—Web of Science (Clarivate Analytics) in May 2024 (https://www.mdpi.com/journal/futurepharmacol/history) and will receive its first Impact Factor in 2025!
Maintaining quality and integrity is integral to our dedication to the research community and is reflected in all our activities. This year, we have focused on rejecting problematic submissions and ensuring precision in our desk review rejections. Additionally, we prioritize providing an excellent publishing experience for researchers in our community.
From everyone here at Future Pharmacology and myself, we wish you all the best for the holiday season and the new year.
Funding
This research received no external funding.
Conflicts of Interest
The author declares no conflicts of interest.
Table 1.
Range of sponsored conferences.
| Conference Name | Location |
|---|---|
| 2024 CSPS/CC-CRS Symposium | Edmonton, Canada |
| CRS 2024 Annual Meeting and Exposition | Bologna, Italy |
| 15th APS PharmSci International Conference | Huddersfield, UK |
| The 17th Chinese Pharmaceutical Conference 2024 | Hangzhou, China |
| Pharmacology 2024 | Harrogate, UK |
Table 2.
Most viewed papers over the last 12 months.
| Title | Views |
|---|---|
| Therapeutic Use of Palmitoylethanolamide as an Anti-Inflammatory and Immunomodulator | 5643 |
| Hereditary Angioedema: Novel Molecules for Treatment of Acute Attacks and Long-Term Prophylaxis | 3904 |
| Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future | 3846 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Schifano, F. 2025: A Bright Year Ahead for Future Pharmacology. Future Pharmacol. 2025, 5, 2. https://doi.org/10.3390/futurepharmacol5010002
AMA Style
Schifano F. 2025: A Bright Year Ahead for Future Pharmacology. Future Pharmacology. 2025; 5(1):2. https://doi.org/10.3390/futurepharmacol5010002
Chicago/Turabian StyleSchifano, Fabrizio. 2025. "2025: A Bright Year Ahead for Future Pharmacology" Future Pharmacology 5, no. 1: 2. https://doi.org/10.3390/futurepharmacol5010002
APA StyleSchifano, F. (2025). 2025: A Bright Year Ahead for Future Pharmacology. Future Pharmacology, 5(1), 2. https://doi.org/10.3390/futurepharmacol5010002
